Conference Coverage

Prescribing a winning home-exercise plan for PAD patients


 

EXPERT ANALYSIS FROM THE NORTHWESTERN VASCULAR SYMPOSIUM

References

Dr. McDermott and her colleagues are testing the boundaries of support in the ongoing HONOR trial, which includes four weekly visits to an exercise center in phase I to meet the telephone coach, learn to use a Fitbit monitor, and learn the behavioral skills necessary for long-term adherence. Phase II, however, is entirely home based and includes only Fitbit self-monitoring, regular telephone calls from the coach for feedback, use of the study website, and optional group telephone calls.

The bottom line with any program is for patients to understand it must be indefinite to maintain improvement.

“Unfortunately, if they don’t stick with it, they will slide back,” she cautioned.

Dr. McDermott reported research funding from the National Institutes of Health, the Patient-Centered Outcomes Research Institute (PCORI), and Novartis.

pwendling@frontlinemedcom.com

Pages

Recommended Reading

USPSTF: Don’t screen general population for carotid stenosis
MDedge Internal Medicine
Cerebral microbleeds’ depth may reveal dementia type
MDedge Internal Medicine
Statins do not worsen diabetes microvascular complications, may be protective
MDedge Internal Medicine
First drug-coated angioplasty balloon approved for PAD
MDedge Internal Medicine
Gout increases risk of vascular disease, especially for women
MDedge Internal Medicine
Nursing home residents have poor outcomes after lower-extremity revascularization
MDedge Internal Medicine
Paclitaxel-coated balloon boosts femoropopliteal angioplasty patency
MDedge Internal Medicine
TCT: Paclitaxel-coated balloon delivers durable SFA patency
MDedge Internal Medicine
AHA: New spotlight on peripheral artery disease
MDedge Internal Medicine
AHA: One in three black Americans will experience PAD
MDedge Internal Medicine